E223-3764 Screening compound: 5-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,6-dimethyl-N-[(4-methylphenyl)methyl]-4-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide

E223-3764 Screening compound: 5-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,6-dimethyl-N-[(4-methylphenyl)methyl]-4-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide
E223-3764 Screening compound: 5-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,6-dimethyl-N-[(4-methylphenyl)methyl]-4-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E223-3764
5-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,6-dimethyl-N-[(4-methylphenyl)methyl]-4-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E223-3764

Molecular Formula

C25H26N4O4 (C25 H26 N4 O4)

Compound Name

5-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,6-dimethyl-N-[(4-methylphenyl)methyl]-4-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide

IUPAC name

5-(23-dihydro-14-benzodioxin-6-yl)-26-dimethyl-N-[(4-methylphenyl)methyl]-4-oxo-4H5H6H7H-pyrazolo[15-a]pyrazine-6-carboxamide

SMILES

CC(Cn1nc(C)cc11)(C(NCc2ccc(C)cc2)=O)N(c(cc2)cc3c2OCCO3)C1=O

InChI

InChI=1S/C25H26N4O4/c1-16-4-6-18(7-5-16)14-26-24(31)25(3)15-28-20(12-17(2)27-28)23(30)29(25)19-8-9-21-22(13-19)33-11-10-32-21/h4-9,12-13H,10-11,14-15H2,1-3H3,(H,26,31)/t25-/m0/s1

InChI Key

APQMHVKVUNHJCW-VWLOTQADSA-N

MDL Number (MFCD)

MFCD27598455

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

446.51

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.855

Distribution Coefficient, logD

1.855

Water Solubility, LogSw

-2.52

Polar Surface Area

68.763

Acid Dissociation Constant (pKa)

12.29

Base Dissociation Constant (pKb)

-1.08

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

32.00

E223-3764 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Cyclic Ugi PPI Library (9586 compounds)

Hsp90-Targeted Library (11355 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system

References: we are preparing a list of scientific research reports with E223-3764 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E223-3764?
Check Price and Availability of E223-3764, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E223-3764 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E223-3764
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E223-3764
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E223-3764 available by request